insights_auto
Why is 9926 down 3.42%?
Dive Deeperchevron_right
9926:HKG
Akeso Inc
HK$95.90
arrow_downward
-3.42%(-3.40) 1D
Sep 22, 4:08:11 PM GMT+8 · HKD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 9926...
Open
HK$97.20
High
HK$98.45
Low
HK$94.85
Mkt. cap
88.34B
Avg. vol.
13.21M
Volume
8.86M
52-wk high
HK$156.00
52-wk low
HK$80.20
EPS
-HK$1.24
No. of employees
4K
Open
HK$97.20
High
HK$98.45
Low
HK$94.85
Mkt. cap
88.34B
Avg. vol.
13.21M
Volume
8.86M
52-wk high
HK$156.00
52-wk low
HK$80.20
EPS
-HK$1.24
No. of employees
4K
News stories
From web sources and news partners
Seeking Alpha
·
1 day ago
Chinese biopharma stocks rally as U.S. signals openness to drug licensing
Profile
Akeso, Inc is a publicly listed Chinese biopharmaceutical company that is headquartered in Zhongshan, Guangdong.
It is best known for developing Ivonescimab, a cancer treatment antibody. Wikipedia
About Akeso Inc
CEOMichelle Xia | Michelle Xia
Employees4.08K
FoundedMar 19, 2012
Headquarters-
SectorBiotechnology
Websiteakesobio.com